Meropenem Aurobindo

Meropenem, the active ingredient in Meropenem Aurobindo, is a carbapenem antibiotic presented as an injection for intravenous use. It treats serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia and septicemia in hospitalized patients.

GNH USA supplies Meropenem Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used for severe bacterial infections that require intravenous therapy.

- Complicated intra‑abdominal infections: achieves bacterial eradication and clinical cure in hospitalized patients. - Complicated urinary tract infections: provides effective eradication of resistant uropathogens. - Nosocomial pneumonia: improves outcomes in ventilator‑associated and hospital‑acquired pneumonia. - Septicemia: rapidly clears bloodstream infections caused by susceptible organisms.

Adverse reactions may occur with any intravenous antibiotic. Monitoring is recommended during therapy.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea or vomiting: transient and usually self‑limiting. - Rash or pruritus: mild skin irritation. - Elevated liver enzymes: transient hepatic enzyme rise. - Phlebitis at injection site: local inflammation. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: especially in patients with CNS disorders or high doses. - Clostridioides difficile‑associated diarrhea: may be severe and life‑threatening. - Severe neutropenia or leukopenia: requires hematologic monitoring. - Renal toxicity: worsening kidney function in susceptible patients. - Hepatic failure: rare but possible in patients with pre‑existing liver disease.

Use meropenem with caution and follow institutional guidelines.

- Renal function: adjust dose in patients with impaired renal clearance. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or other β‑lactams. - Seizure risk: monitor patients with a history of seizures or receiving high doses. - Pregnancy and lactation: use only when the potential benefit justifies the potential risk. - Drug interactions: review concomitant medications that may lower seizure threshold. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several co‑administered drugs; clinicians should assess risk versus benefit.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate levels, increasing seizure risk. - Probenecid: may increase meropenem plasma concentrations, raising toxicity potential.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxicity; monitor renal function. - Loop diuretics: additive renal stress; adjust dosing as needed. - Other β‑lactam antibiotics: additive neurotoxicity; observe for CNS effects. - Anticoagulants (e.g., warfarin): possible alteration of INR; monitor coagulation parameters.